
Accenture acquires Alfahealth adding 1,200 professionals
- Accenture has signed an agreement to acquire Alfahealth, a prominent Italian digital health subsidiary of Engineering Group.
- Following the transaction announcement, the company's common stock closed slightly higher at $165.84 per share.
- The acquisition is driven by a long-term corporate strategy to scale integrated cloud and artificial intelligence healthcare platforms.
Accenture (NYSE:ACN) has agreed to acquire Alfahealth, a digital health subsidiary of Engineering Group, to expand its healthcare capabilities in Italy by adding 1,200 specialized professionals.
This domestic expansion arrives as Italy experiences growing public and private investments in clinical process digitization and healthcare system interoperability.
The financial terms of the transaction were not disclosed, and final completion remains entirely subject to customary closing conditions.
The integration intends to scale the subsidiary's service model using advanced cloud and artificial intelligence platforms, and following the announcement, Accenture's share price was up at $165.84.
The professional services firm has focused its broader corporate strategy on combining software, data, and AI-powered platforms to drive sustainable end-to-end transformation for enterprise clients.
This regional acquisition follows separate strategic moves by the business to reinforce its global cybersecurity, data analytics, and cloud infrastructure divisions.
Frequently asked questions
More from United States
AbbVie revenue increases 10.3% to $17.4 billion in third quarter
Sensient Q3 revenue rockets 10.6% to $455.8 million
Cameco Q3 adjusted loss reaches CA$2 million as uranium output falls
Kite Realty Q3 loss narrows to $13.3 million as NOI grows
Largo cuts 2026 vanadium production outlook to 9,500–10,500 tonnes
nVent Q3 sales jump 44% as shares fall despite higher revenue